Editors' (re)View

Welcome to Editors' (re)View, our editors’ weekly takes on things going on in the pharma world that deserve some extra consideration.

Articles

Editors' (re)View: Boehringer’s AI push; Busy week for Phenomic

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of November 27

Editors' (re)View: Meals minus the stuffing; Antibiotics in your turkey?

Pharma Manufacturing editors comment on the notable happenings in the pharma industry from the week of November 20

Editors' (re)View: A historic moment in biotech

Pharma Manufacturing editors comment on the notable happenings in the pharma industry from the week of November 13.
Screen Shot 2023 04 21 At 11 47 08 Am 6467a3da911ba

Editors' (re)View:Contraception gel less effective than claims; Can tirzepatide usurp Humira?

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of November 6
Screen Shot 2023 04 21 At 11 47 08 Am 6455034c68cb6

Editors' (re)View: Hope for BCG alternatives; AdComm casts positive light on SCD therapy

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of October 30
Screen Shot 2023 04 21 At 11 47 08 Am 6467a3da911ba

Editors (re)View: Innovative takeaways from CPHI

Bright ideas shine on the tradeshow floor
Screen Shot 2023 04 21 At 11 47 08 Am 6467a3da911ba

Editors' (re)View: Innovating to meet customer needs; ADC moves

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of October 16.
Screen Shot 2023 04 21 At 11 47 08 Am 6467a3da911ba

Editors' (re)View: EU rejects Amylyx ALS drug; Alvotech's problematic Reykjavik facility

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of October 10
Screen Shot 2023 04 21 At 11 47 08 Am 6455034c68cb6

Editors' (re)View: Lilly goes radioactive; Pharma fights back against the FTC

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of October 2
Screen Shot 2023 07 07 At 11 16 33 Am

Editors' (re)View: COVID BARDA bucks; BrainStorm ALS hopeful fails to impress

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of September 25
Screen Shot 2023 07 07 At 11 16 33 Am

Editors' (re)View: Nasal epinephrine hits roadblocks; Mesoblast comes closer to winning

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of September 18
Screen Shot 2023 07 07 At 11 16 33 Am

Editors' (re)View: Phenylephrine doesn't work; J&J changes the script

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of September 11.
Screen Shot 2023 07 07 At 11 16 33 Am

Editors' (re)View: Nestlé gives up on peanut allergy drug; Next-level ADCs

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of September 4
Screen Shot 2023 07 07 At 11 16 33 Am

Editors' (re)View: Outlook stays positive; FTC clears Amgen-Horizon deal

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of August 28
Screen Shot 2023 07 07 At 11 16 33 Am

Editors' (re)View: Affordable MS treatment option; A chance to date Martin Shkreli

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of August 21